Evidence map›Paper›PMID 25253345›Full record

ArticleJournal of virology2014

Evolution of bluetongue virus serotype 1 in northern Australia over 30 years.

David B Boyle, Rachel Amos-Ritchie, Ivano Broz, Peter J Walker, Lorna Melville, David Flanagan, Steven Davis, Neville Hunt, Richard Weir

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
6.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

David B BoyleCSIRO Biosecurity, Australian Animal Health Laboratory, Geelong, Victoria, Australia peter.walker@csiro.au david.boyle@csiro.au.
Rachel Amos-RitchieCSIRO Biosecurity, Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Ivano BrozCSIRO Biosecurity, Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Peter J WalkerCSIRO Biosecurity, Australian Animal Health Laboratory, Geelong, Victoria, Australia peter.walker@csiro.au david.boyle@csiro.au.
Lorna MelvilleNorthern Territory Department of Resources, Berrimah Veterinary Laboratories, Berrimah, Northern Territory, Australia.
David FlanaganNorthern Territory Department of Resources, Berrimah Veterinary Laboratories, Berrimah, Northern Territory, Australia.
Steven DavisNorthern Territory Department of Resources, Berrimah Veterinary Laboratories, Berrimah, Northern Territory, Australia.
Neville HuntNorthern Territory Department of Resources, Berrimah Veterinary Laboratories, Berrimah, Northern Territory, Australia.
Richard WeirNorthern Territory Department of Resources, Berrimah Veterinary Laboratories, Berrimah, Northern Territory, Australia.
Commonwealth Scientific and Industrial Research Organisation · AUAustralian Centre for Disease Preparedness · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledBluetongue virus serotype 1 (BTV 1) was first isolated in Australia from cattle blood collected in 1979 at Beatrice Hill Farm (BHF), Northern Territory (NT). From long-term surveillance programs (1977 to 2011), 2,487 isolations of 10 BTV serotypes were made. The most frequently isolated serotype was BTV 1 (41%, 1,019) followed by BTV 16 (17.5%, 436) and BTV 20 (14%, 348). In 3 years, no BTVs were isolated, and in 12 years, no BTV 1 was isolated. Seventeen BTV 1 isolates were sequenced and analyzed in comparison with 10 Australian prototype serotypes. BTV 1 showed an episodic pattern of evolutionary change characterized by four distinct periods. Each period consisted primarily of slow genetic drift which was punctuated from time to time by genetic shifts generated by segment reassortment and the introduction of new genome segments. Evidence was found for coevolution of BTV genome segments. Evolutionary dynamics and selection pressure estimates showed strong temporal and clock-like molecular evolutionary dynamics of six Australian BTV genome segments. Bayesian coalescent estimates of mean substitution rates clustered in the range of 3.5 × 10(-4) to 5.3 × 10(-4) substitutions per site per year. All BTV genome segments evolved under strong purifying (negative) selection, with only three sites identified as under pervasive diversifying (positive) selection. The obligate replication in alternate hosts (insect vector and vertebrate hosts) imposed strong evolutionary constraints. The dominant mechanism generating genetic diversity of BTV 1 at BHF was through the introduction of new viruses and reassortment of genome segments with existing viruses. IMPORTANCE: Bluetongue virus (BTV) is the causative agent of bluetongue disease in ruminants. It is a disease of concern globally and is transmitted by biting midges (Culicoides species). Analysis of the evolutionary and selection pressures on BTV 1 at a single surveillance site in northern Australia showed strong temporal and clock-like dynamics. Obligate replication in alternate hosts of insect and vertebrate imposed strong evolutionary constraints, with all BTV genome segments evolving under strong purifying (negative) selection. Generation of genetic diversity of BTV 1 in northern Australia is through genome segment reassortment and the introduction of new serotypes.

Indexed as

Genetic VariationAnimalsAustraliaBluetongueBluetongue virusCattleCluster AnalysisEvolution, MolecularGenetic DriftGenotypeMolecular EpidemiologyMolecular Sequence DataPhylogenyReassortant VirusesRecombination, GeneticRNA, ViralRNA, Viral

Identifiers

PMID25253345
PMCPMC4249141
OpenAlexW2083332661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.